Physica Medica: European Journal of Medical Physics
Volume 25, Issue 2 , Pages 82-87 , June 2009

Biodosimetry using micronucleus assay in acute partial body therapeutic irradiation

  • Srinivasan Senthamizhchelvan

      Affiliations

    • Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari nagar, New Delhi 110 029, India
    • Department of Radiotherapy, All India Institute of Medical Sciences, Ansari nagar, New Delhi 110 029, India
    • Corresponding Author InformationCorresponding author. Department of Radiotherapy, All India Institute of Medical Sciences, Ansari nagar, New Delhi 110 029, India.
    • ,
  • G.S. Pant

      Affiliations

    • Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari nagar, New Delhi 110 029, India
    • ,
  • G.K. Rath

      Affiliations

    • Department of Radiotherapy, All India Institute of Medical Sciences, Ansari nagar, New Delhi 110 029, India
    • ,
  • P.K. Julka

      Affiliations

    • Department of Radiotherapy, All India Institute of Medical Sciences, Ansari nagar, New Delhi 110 029, India
    • ,
  • O. Nair

      Affiliations

    • Department of Radiotherapy, All India Institute of Medical Sciences, Ansari nagar, New Delhi 110 029, India

Received 14 October 2007 ,Revised 2 May 2008 ,Accepted 16 May 2008.

References 

  1. Baranov AE, Guskova AK, Nadejina NM, Nugis VY. Chernobyl experience: biological indicators of exposure to ionizing radiation. Stem Cells. 1995;13:69–77
  2. Ramalho AT, Nascimento ACH, Natarajan AT. Dose assessments by cytogenetic analysis in the Goiania (Brazil) radiation accident. Radiat Prot Dosimetry. 1988;25:97–100
  3. Littlefield LG, Joiner EE, Colver SP, Ricks RC, Lustbaugh CC, Hurtado-Monroy R. The 1989 San Salvador 60 Co radiation accident: cytogenetic dosimetry and follow-up evaluations in three accident victims. Radiat Prot Dosimetry. 1991;35:115–123
  4. Bauchinger M. Cytogenetic research after accidental radiation exposure. Stem Cells. 1995;3:182–190
  5. Natarajan AT. Chromosome aberrations: past, present and future. Mutat Res. 2002;504:3–16
  6. Countryman PI, Heddle JA. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat Res. 1976;41:321–331
  7. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemmink K, Merlo F, et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International program on chemical safety. Mutat Res. 2000;463:111–172
  8. Fenech M. Cytokinesis-block micronucleus assay evolves into a “cytome” assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res. 2006;600:58–66
  9. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis. 2007;28:625–631
  10. Lee TK, O'Brien KF, Naves JL, Christie KI, Arastu HH, Eaves GS, et al. Micronuclei in lymphocytes of prostate cancer patients undergoing radiation therapy. Mutat Res. 2000;469:63–70
  11. Thierens H, Vral A, Van Eijkeren M, Spelman F, de Riddle L. Micronucleus induction in peripheral blood lymphocytes of patients under radiotherapy treatment for cervical cancer or Hodgkin's disease. Int J Radiat Biol. 1995;67:529–539
  12. Venkatachalam P, Solomon FD, Prabhu BK, Mohankumar MN, Gajendiran N, Jeevanram RK. Estimation of dose in cancer patients treated with fractionated radiotherapy using translocation, dicentrics and micronuclei frequency in peripheral blood lymphocytes. Mutat Res. 1999;429:1–12
  13. Wojcik A, Stephan G, Sommer S, Buraczewska I, Kuszewski T, Wieczorek A, et al. Chromosomal aberrations and micronuclei in lymphocytes of breast cancer patients after an accident during radiotherapy with 8 MeV electrons. Radiat Res. 2003;160:677–683
  14. Catena C, Conti D, Parasacchi P, Marenco P, Bortolato B, Botturi M, et al. Micronuclei in cytokinesis-blocked lymphocytes may predict patient response to radiotherapy. Int J Radiat Biol. 1996;70:301–308
  15. Widel M, Jedrus S, Owczarek S, Konopacka M, Lubecka B, Kolosza Z. The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability. Br J Cancer. 1999;80:1599–1607
  16. Widel M, Kolosza Z, Jedrus S, Lukaszczyk B, Raczek-Zwierzycka K, Swierniak A. Micronucleus assay in vivo provides significant prognostic information in human cervical carcinoma; the updated analysis. Int J Radiat Biol. 2001;7:631–636
  17. Widel M, Jedrus S, Lukaszczyk B, Raczek-Zwierzycka K, Swierniak A. Radiation-induced micronucleus frequency in peripheral blood lymphocytes is correlated with normal tissue damage in patients with cervical carcinoma undergoing radiotherapy. Radiat Res. 2003;159:713–721
  18. Jagetia GC, Jayakrishnan A, Fernandes D, Vidyasagar MS. Evaluation of micronuclei frequency in the cultured peripheral blood lymphocytes of cancer patients before and after radiation treatment. Mutat Res. 2001;491:9–16
  19. Jianlin L, Jiliang H, Lifen J, Wei Z, Baohong W, Hongping D. Measuring the genetic damage in cancer patients during radiotherapy with three genetic end-points. Mutagenesis. 2004;19:457–464
  20. Fenech M, Denham J, Francis W, Morley A. Micronuclei in cytokinesis-blocked lymphocytes of cancer patients following fractionated partial-body radiotherapy. Int J Radiat Biol. 1990;57:373–383
  21. Gantenberg HW, Wuttke K, Streffer C, Muller WU. Micronuclei in human lymphocytes irradiated in vitro or in vivo. Radiat Res. 1991;128:276–281
  22. Silva-Barbosa I, Pereira-Magnata S, Amaral A, Sotero G, Melo HC. Dose assessment by quantification of chromosome aberrations and micronuclei in peripheral blood lymphocytes from patients exposed to gamma radiation. Genet Mol Biol. 2005;28:452–457
  23. Monsieurs M, Thierens H, Vral A, Brans B, De Ridder L, Dierckx RA. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumors. Nucl Med Commun. 2001;22:367–374
  24. Erselcan T, Sungu S, Ozdemir S, Turgut B, Dogan D, Ozdemir O. Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship. Eur J Nucl Med Mol Imaging. 2004;31:676–684
  25. M'Kacher R, Legal JD, Schlumberger M, Voisin P, Aubert B, Gaiilard N, et al. Biologic dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. J Nucl Med. 1996;37:1860–1864
  26. Gutierrez S, Carbonell E, Galofre P, Creus A, Marcos R. Cytogenetic damage after iodine-131 treatment for hyperthyroidism and thyroid cancer: a study using the micronuclei test. Eur J Nucl Med. 1999;26:1589–1596
  27. Monteiro O, Oliveira NG, Rodrigues AS, Laires A, Ferreira TC, Limert E, et al. Alterations and oxidative stress in thyroid cancer patients after iodine-131 therapy. Mutagenesis. 2000;15:69–75
  28. Ballardin M, Gemignani F, Bodei L, Mariani G, Ferdeghini M, Rossi AM, et al. Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Mutat Res. 2002;514:77–85
  29. Grawe J, Biko J, Lorenz R, Reiners C, Stopper H, Vershenya S, et al. Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer. Mutat Res. 2005;583:12–25
  30. Kinashi Y, Sakurai Y, Masunaga S, Suzuki M, Nagata K, Ono K. Evaluation of micronucleus induction in lymphocytes of patients following boron-neutron-capture-therapy: a comparison with thyroid cancer patients treated with radioiodine. J Radiat Res. 2007;48:197–204
  31. Song EY, Rizvi SM, Qu CF, Raja C, Yuen J, Li Y, et al. The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy. Phys Med Biol. 2008;53:319–328
  32. Urbanik W, Kukołowicz P, Kuszewski T, Gozdz S, Wojcik A. Modelling the frequencies of chromosomal aberrations in peripheral lymphocytes of patients undergoing radiotherapy. Nukleonika. 2003;48:3–8
  33. Jones LA, Scott D, Cowan R, Roberts SA. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int J Radiat Biol. 1995;67:519–528
  34. Louagie H, Van Eijkeren M, Philippe J, Thierens H, de Ridder L. Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapy. Int J Radiat Biol. 1999;75:767–771
  35. Taghavi-Dehaghani M, Mohammadi S, Ziafazeli T, Sardari-Kermani M. A study on differences between radiation-induced micronuclei and apoptosis of lymphocytes in breast cancer patients after radiotherapy. Z Naturforsch C. 2005;60:938–942
  36. Savage JRK. Sites of radiation induced chromosome exchanges. Curr Top Radiat Res. 1970;6:129–194
  37. Senthamizhchelvan S, Pant GS, Rath GK, Julka PK, Nair O, Prabhakar R. Biological estimation of dose in hemi-body irradiation of cancer patients by cytogenetic analysis. Health Phys. 2008;94:112–117
  38. Dolphin GW. Biological dosimetry with particular reference to chromosome aberration analysis. A review of methods. Vienna: International Atomic Energy Agency; 1969;215–224
  39. Matsubara S, Sasaki MS, Adachi T. Dose-response relationship of lymphocyte chromosome aberrations in locally irradiated persons. J Radiat Res. 1974;15:189–196
  40. Durante M, Yamada S, Ando K, Furusawa Y, Kawata T, Majima H, et al. Measurements of the equivalent whole-body dose during radiation therapy by cytogenetic methods. Phys Med Biol. 1999;44:1289–1298
  41. Durante M, Yamada S, Ando K, Furusawa Y, Kawata T, Majima H, et al. X-rays vs. carbon-ion tumor therapy: cytogenetic damage in lymphocytes. Int J Radiat Oncol Biol Phys. 2000;47:793–798
  42. d'Alesio V, Pacelli R, Durante M, Canale Cama G, Cella L, Gialanella G, et al. Lymph nodes in the irradiated field influence the yield of radiation-induced chromosomal aberrations in lymphocytes from breast cancer patients. Int J Radiat Oncol Biol Phys. 2003;57:732–738
  43. Sreedevi B, Rao BS, Nagaraj H, Pal NK. Chromosome aberration analysis in radiotherapy patients and simulated partial body exposures: biological dosimetry for non-uniform exposures. Radiat Prot Dosimetry. 2001;94:317–322
  44. Heimers A, Brede HJ, Giesen U, Hoffmann W. Chromosome aberration analysis and the influence of mitotic delay after simulated partial-body exposure with high doses of sparsely and densely ionising radiation. Radiat Environ Biophys. 2006;45:45–54
  45. Senthamizhchelvan S, Pant GS, Rath GK, Julka PK, Nair O, Joshi RC. Biodosimetry using chromosome aberrations in human lymphocytes. Radiat Prot Dosimetry. 2007;123:241–245

PII: S1120-1797(08)00066-5

doi: 10.1016/j.ejmp.2008.05.004

Physica Medica: European Journal of Medical Physics
Volume 25, Issue 2 , Pages 82-87 , June 2009

Article Tools

* Image Usage & Resolution